首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   125187篇
  免费   5592篇
  国内免费   254篇
耳鼻咽喉   1821篇
儿科学   3979篇
妇产科学   2967篇
基础医学   16887篇
口腔科学   3372篇
临床医学   7851篇
内科学   29027篇
皮肤病学   3677篇
神经病学   10137篇
特种医学   2785篇
外国民族医学   2篇
外科学   15900篇
综合类   607篇
一般理论   36篇
预防医学   13596篇
眼科学   3069篇
药学   9133篇
中国医学   461篇
肿瘤学   5726篇
  2023年   704篇
  2022年   509篇
  2021年   2256篇
  2020年   1147篇
  2019年   2604篇
  2018年   4521篇
  2017年   2685篇
  2016年   2453篇
  2015年   2634篇
  2014年   2942篇
  2013年   4898篇
  2012年   8323篇
  2011年   8832篇
  2010年   4409篇
  2009年   2991篇
  2008年   7113篇
  2007年   7556篇
  2006年   7154篇
  2005年   7249篇
  2004年   6699篇
  2003年   6279篇
  2002年   5900篇
  2001年   4139篇
  2000年   4629篇
  1999年   3317篇
  1998年   636篇
  1997年   395篇
  1996年   415篇
  1992年   1318篇
  1991年   1193篇
  1990年   1124篇
  1989年   1005篇
  1988年   931篇
  1987年   907篇
  1986年   842篇
  1985年   826篇
  1984年   626篇
  1983年   490篇
  1979年   598篇
  1978年   367篇
  1976年   331篇
  1975年   362篇
  1974年   535篇
  1973年   499篇
  1972年   429篇
  1971年   395篇
  1970年   464篇
  1969年   429篇
  1968年   407篇
  1967年   373篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Journal of Digital Imaging - Vertebral Compression Fracture (VCF) occurs when the vertebral body partially collapses under the action of compressive forces. Non-traumatic VCFs can be secondary to...  相似文献   
43.
Clinical Rheumatology - We aimed to estimate the frequency of overlap of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with systemic autoimmune diseases. Retrospective...  相似文献   
44.
45.
European Journal of Clinical Microbiology & Infectious Diseases - We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a...  相似文献   
46.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
47.
48.
49.
IntroductionPain is highly prevalent in patients with multiple sclerosis (MS); it is chronic in 50% of cases and is classified as nociceptive, neuropathic, or mixed-type. Pain affects quality of life, sleep, and the activities of daily living. Electrotherapy is an interesting alternative or complementary treatment in the management of pain in MS, with new innovations constantly appearing.Material and methodsThis study evaluates the effectiveness of treatment with monopolar dielectric transmission of pulsed electromagnetic fields (PEMF) for pain associated with MS. We performed a randomised, placebo-controlled clinical trial including 24 patients, who were assessed with the Brief Pain Inventory, the Multiple Sclerosis International Quality of Life questionnaire, the Beck Depression Inventory, and the Modified Fatigue Impact Scale.ResultsStatistically significant improvements were observed in maximum and mean pain scores, as well as in the impact of pain on work, personal relationships, and sleep and rest. Not significant differences were found between the treatment and placebo groups.ConclusionsTreatment with PEMF may be effective in reducing pain in patients with MS, although further research is necessary to confirm its effectiveness over placebo and to differentiate which type of pain may be more susceptible to this treatment.  相似文献   
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号